Search Results - "Okazaki, Kyoko"

Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca2+ Channels, on Visceral Pain in Mice by Tsubota, Maho, Matsui, Kazuki, Fukushi, Saaya, Okazaki, Kyoko, Sekiguchi, Fumiko, Kawabata, Atsufumi

“…T-Type Ca2+ channels (T-channels), particularly Cav3.2, are now considered as therapeutic targets for treatment of intractable pain including visceral pain…”
Get full text

Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H2S/Cav3.2 Signaling in Mice by Hiramoto, Shiori, Tsubota, Maho, Yamaguchi, Kaoru, Okazaki, Kyoko, Sakaegi, Aya, Toriyama, Yuki, Tanaka, Junichi, Sekiguchi, Fumiko, Ishikura, Hiroyasu, Wake, Hidenori, Nishibori, Masahiro, Nguyen, Huy Du, Okada, Takuya, Toyooka, Naoki, Kawabata, Atsufumi

“…Cystitis-related bladder pain involves RAGE activation by HMGB1, and increased Cav3.2 T-type Ca2+ channel activity by H2S, generated by upregulated…”
Get full text

Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca2+ Channels, on Visceral Pain in Mice by Maho Tsubota, Kazuki Matsui, Saaya Fukushi, Kyoko Okazaki, Fumiko Sekiguchi, Atsufumi Kawabata

“…T-Type Ca2+ channels (T-channels), particularly Cav3.2, are now considered as therapeutic targets for treatment of intractable pain including visceral pain…”
Get full text

Successful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma by Takeno, Ayumu, Yamamoto, Masahiro, Okazaki, Kyoko, Yamaguchi, Toru, Sugimoto, Toshitsugu

“…Bone metabolic disorders in patients with prolactinoma have not been fully characterized. The case presented herein illustrates potential causal associations…”
Get full text

Partial Improvement of Anterior Pituitary Deficiency Following Steroid Treatment in a Patient with Neurosarcoidosis Accompanied by Central Diabetes Insipidus by Tanaka, Ken-ichiro, Yamamoto, Masahiro, Okazaki, Kyoko, Yamaguchi, Toru, Sugimoto, Toshitsugu

“…A 58-year-old woman was admitted due to visual field abnormalities, thirst, polydipsia, polyuria and fever. T1-weighted magnetic resonance imaging revealed an…”
Get full text

Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (−)‐N‐(trans‐4‐isopropylcyclohexane‐carbonyl)‐d‐phenylalanine (A‐4166) by Ikenoue, Takao, Akiyoshi, Megumi, Fujitani, Shoji, Okazaki, Kyoko, Kondo, Nobuo, Maki, Toshio

“…(−)‐N‐(trans‐4‐isopropylcyclohexanecarbonyl)‐d‐phenylalanine (A‐4166), a novel oral hypoglycaemic agent is a non‐sulphonylurea insulin secretagogue. We…”
Get full text

Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis by Okazaki, Kyoko, Yamaguchi, Toru, Tanaka, Ken-ichiro, Notsu, Masakazu, Ogawa, Noriko, Yano, Shozo, Sugimoto, Toshitsugu

“…Diabetes mellitus is known to be associated with osteoporotic fractures through a decrease in osteoblastic bone formation rather than an increase in…”
Get full text

Advanced Glycation End Product 3 (AGE3) Suppresses the Mineralization of Mouse Stromal ST2 Cells and Human Mesenchymal Stem Cells by Increasing TGF-β Expression and Secretion by Notsu, Masakazu, Yamaguchi, Toru, Okazaki, Kyoko, Tanaka, Ken-ichiro, Ogawa, Noriko, Kanazawa, Ippei, Sugimoto, Toshitsugu

“…In diabetic patients, advanced glycation end products (AGEs) cause bone fragility because of deterioration of bone quality. We previously showed that AGEs…”
Get full text

Effects of Bepridil and Pimozide, Existing Medicines Capable of Blocking T-Type Ca 2+ Channels, on Visceral Pain in Mice by Tsubota, Maho, Matsui, Kazuki, Fukushi, Saaya, Okazaki, Kyoko, Sekiguchi, Fumiko, Kawabata, Atsufumi

“…T-Type Ca channels (T-channels), particularly Ca 3.2, are now considered as therapeutic targets for treatment of intractable pain including visceral pain…”
Get full text

Mixed Corticomedullary Tumors of the Adrenal Gland Harboring Both Medullary and Cortical Properties by Inoue, Aiko, Inoue, Sachika, Sawai, Rui, Hamamatsu, Keita, Okazaki, Kyoko, Nishizawa, Hitoshi, Yamazaki, Yuto, Sasano, Hironobu, Murabe, Hiroyuki, Yokota, Toshihiko

“…Adrenal cortex and medulla are derived from mesoderm and ectoderm, respectively. Mixed corticomedullary tumors (MCMTs), comprising an intimately admixed…”
Get full text

The ability of a new hypoglycaemic agent, A‐4166, compared to sulphonylureas, to increase cytosolic Ca 2+ in pancreatic β‐cells under metabolic inhibition by Fujitani, Shoji, Okazaki, Kyoko, Yada, Toshihiko

“…N ‐( trans ‐4‐isopropylcyclohexanecarbonyl)‐ d ‐phenylalanine (A‐4166) is a new non‐sulphonylurea oral hypoglycaemic agent which stimulates insulin release by…”
Get full text

SUN-555 Clinical Outcomes of Thyroid Storm at Kurashiki Central Hospital: Effectiveness of Clinical Criteria and Severity Scores by Itoh, Yoshihiko, Inoue, Aiko, Okamoto, Kentaro, Kawashima, Akiyuki, Hamamatsu, Keita, Okazaki, Kyoko, Nishizawa, Hitoshi, Murabe, Hiroyuki, Yokota, Toshihiko

“…BACKGROUND: Thyroid storm (TS) is a life-threatening condition requiring emergency treatment. The reported mortality of TS is 10-20%, but there have not been…”
Get full text

Effect of a New Hypoglycemic Agent, A-4166 ((-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine), on Postprandial Blood Glucose Excursion: Comparison with Voglibose and Glibenclamide by IKENOUE, Takao, OKAZAKI, Kyoko, FUJITANI, Shoji, TSUCHIYA, Yoshiharu, AKIYOSHI, Megumi, MAKI, Toshio, KONDO, Nobuo

Get full text

Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream [H.sub.2]S/[Ca.sub.v]3.2 Signaling in Mice by Hiramoto, Shiori, Tsubota, Maho, Yamaguchi, Kaoru, Okazaki, Kyoko, Sakaegi, Aya, Toriyama, Yuki, Tanaka, Junichi, Sekiguchi, Fumiko, Ishikura, Hiroyasu, Wake, Hidenori, Nishibori, Masahiro, Nguyen, Huy Du, Okada, Takuya, Toyooka, Naoki, Kawabata, Atsufumi

“…Cystitis-related bladder pain involves RAGE activation by HMGB1, and increased [Ca.sub.v]3.2 T-type [Ca.sup.2+] channel activity by [H.sub.2]S, generated by…”
Get full text

Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H 2 S/Ca v 3.2 Signaling in Mice by Hiramoto, Shiori, Tsubota, Maho, Yamaguchi, Kaoru, Okazaki, Kyoko, Sakaegi, Aya, Toriyama, Yuki, Tanaka, Junichi, Sekiguchi, Fumiko, Ishikura, Hiroyasu, Wake, Hidenori, Nishibori, Masahiro, Nguyen, Huy Du, Okada, Takuya, Toyooka, Naoki, Kawabata, Atsufumi

“…Cystitis-related bladder pain involves RAGE activation by HMGB1, and increased Ca 3.2 T-type Ca channel activity by H S, generated by upregulated…”
Get full text

Effect of a New Hypoglycemic Agent, A-4166 [(-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine], on Postprandial Blood Glucose Excursion : Comparison with Voglibose and Glibenclamide by IKENOUE, Takao, OKAZAKI, Kyoko, FUJITANI, Shoji, TSUCHIYA, Yoshiharu, AKIYOSHI, Megumi, MAKI, Toshio, KONDO, Nobuo

“…(-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166) is a new nonsulfonylurea hypoglycemic agent that lowers blood glucose by stimulating…”
Get full text

The ability of a new hypoglycaemic agent, A‐4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic β‐cells under metabolic inhibition by Fujitani, Shoji, Okazaki, Kyoko, Yada, Toshihiko

“…N‐(trans‐4‐isopropylcyclohexanecarbonyl)‐d‐phenylalanine (A‐4166) is a new non‐sulphonylurea oral hypoglycaemic agent which stimulates insulin release by…”
Get full text

BACTERIOLOGICAL STUDIES ON CARFECILLIN, A NEW ORAL CARBENICILLIN by OTSUKI, MASAKO, NISHINO, TAKESHI, TODA, MASATO, OKAZAKI, KYOKO, NAKAZAWA, SHOZO

“…1. Antibacterial spectrum of carfecillin is the same as that of CBPC and I-CBPC, and its antibacterial activity is almost similar to that of CBPC, while it is…”
Get full text

BACTERIOLOGICAL STUDIES ON CARBENICILLIN INDANYL SODIUM, A NEW ORAL SYNTHETIC PENICILLIN by OTSUKI, MASAKO, NISHINO, TAKESHI, OKAZAKI, KYOKO, TODA, MASATO, NAKAZAWA, SHOZO

“…A bacteriological evaluation was performed on carbenicillin indanyl sodium (I-CBPC) using carbenicillin (CBPC) as a control and the following results were…”
Get full text

Effect of a New Hypoglycemic Agent, A-4166 [(-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine], on Postprandial Blood Glucose Excursion by IKENOUE, Takao, OKAZAKI, Kyoko, FUJITANI, Shoji, TSUCHIYA, Yoshiharu, AKIYOSHI, Megumi, MAKI, Toshio, KONDO, Nobuo

“…(-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166) is a new nonsulfonylurea hypoglycemic agent that lowers blood glucose by stimulating…”
Get full text